filmov
tv
From discovery to market: The role of IP strategy in drug development
Показать описание
With vaccine brand names still very much top-of-mind for Canadians, Gowling WLG's own Brian Kingwell and Dr. Sonia Ziesche took part in a recent online panel discussion surrounding drug development and intellectual property. The event touched on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis, international filing strategies and portfolio management, and the unique industry challenges brought to light due to the COVID-19 pandemic.
This video may contain information of general interest about current legal issues, but does not give legal advice.
This video may contain information of general interest about current legal issues, but does not give legal advice.